about
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCThe Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core ComplexRecombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferretsCryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion.Dissecting virus entry: replication-independent analysis of virus binding, internalization, and penetration using minimal complementation of β-galactosidaseSevere acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies.Manipulation of the porcine epidemic diarrhea virus genome using targeted RNA recombination.Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.Membrane ectopeptidases targeted by human coronaviruses.Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.Novel polymeric inhibitors of HCoV-NL63.Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range.Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor.The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity.Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein.Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry.Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels.SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements.Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent.Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion.Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus.Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture.Transmission of MERS-coronavirus in household contacts.Spiking the MERS-coronavirus receptorCathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptideCentral ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoproteinQuantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles
P50
Q24329089-050B43A6-5727-4A1F-A7FE-5A7F05BE0C65Q27477706-77C87F81-C18C-49C7-A8F9-559E18D45107Q30392305-E357452B-ACB2-4DFC-8BBA-5CCA803665BEQ30485308-1BE4C8F5-15D1-4ABE-90B1-ABA5D1F2E4C6Q33904625-73C184CA-E9AD-4F47-8B3E-00A0642B9502Q34376025-63AB0CB1-6234-4195-B915-DCFF21A26A82Q34653419-4B6C7482-FC38-40A8-B6A8-F6CF65CE42FEQ34924832-38169E56-40B7-48C6-B937-910D7140007BQ35399141-641F1F59-E9F3-411E-AD10-0F0AE48F0131Q38206913-E62A58FB-CDEC-4494-9EF0-695ACBC4AB67Q38860071-716E5D68-5D96-439C-A21E-B37161B934E7Q39234644-C76F03DE-955A-40BF-B01D-844744F592A3Q39306200-644DD81E-EC67-467B-9112-ED5E2956901DQ39613000-144A0AAA-B05B-44D5-BFAE-B43F991C0F08Q39707715-577CA359-FE96-4BD2-B856-C988C06BB22AQ40035989-CE5F9EB0-E48E-4511-91C0-827FB7093311Q40126225-45A8D20D-D2D7-44DA-BDC0-93A437A6538AQ40220808-4545F39A-7B84-4135-B543-8213A37AE6E2Q40275624-0C7B94A5-F064-434B-A75E-219DD28D04B5Q40336588-2F8FA36A-64DB-4370-8EDF-B5F3D15D987CQ40341738-0E080DBB-4C7D-4064-AE45-D3FAAB7050AEQ40444606-82C636AE-006A-4C90-B6FC-3BA4AC9F8BAEQ40541143-D7C60D27-F26C-44B2-8073-44CF1DCE8862Q40883625-946658A2-CC56-403B-86CA-815D61C8F066Q41908949-194F7965-3B0B-4C88-AA8C-68CF48028EE6Q41920484-3FA6E834-3446-4787-B2AB-392B02AD3158Q41975503-AB0FB642-11B4-4FF0-AC1D-071F6270CB64Q42197387-0C114D61-B026-4494-9823-C8BCDEA4B13DQ42251362-2EDDF3C3-D7C1-4251-BDA0-9258259E407DQ42407073-302B08CC-E7A2-4AFF-A708-7FE627C08C70Q56762915-5143750F-24C7-4850-B644-79CF21EFC0C7Q82177423-09BC59C5-BD00-4F74-832B-D8C707BBDFCC
P50
name
Berend Jan Bosch
@en
type
label
Berend Jan Bosch
@en
prefLabel
Berend Jan Bosch
@en